SCHEMBL9198802

SCHEMBL9198802

O=C1CC(c2ccccc2)C2(c3cccnc3-c3ncccc32)C(c2ccccc2)C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
GAA P10253 3/20 0.35
MAPT P10636 2/20 0.35
PDK2 Q15119 2/20 0.35
ALDH1A1 P00352 1/20 0.35
PTPRC P08575 2/20 0.34
CTSL P07711 1/20 0.34
CTSS P25774 1/20 0.34
PTPN13 Q12923 1/20 0.34
KMT2A Q03164 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C19 P33261 2/20 0.34
TDP2 O95551 1/20 0.33
NSD2 O96028 1/20 0.33
ABL1 P00519 1/20 0.33
PLCG1 P19174 1/20 0.33
CES1 P23141 1/20 0.33
PAX8 Q06710 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9199038 0.90 NFKB1 (0.35) NFKB1NFKB2RELAGAAMAPT
SCHEMBL9200820 0.87 CYP2A6 (0.40) MAPTALDH1A1KMT2ACYP1A2CYP2C19
SCHEMBL9545532 0.84 MAPT (0.35) NFKB1NFKB2RELAGAAMAPT
SCHEMBL9194471 0.84 GSK3B (0.47) MAPTPDK2ALDH1A1PTPRCCTSL
SCHEMBL9195303 0.80 CYP2A6 (0.36) GAAPDK2PTPRCCTSLCTSS
SCHEMBL9198100 0.79 NFKB1 (0.46) NFKB1NFKB2RELAGAAMAPT
SCHEMBL9198107 0.79 NFKB1 (0.46) NFKB1NFKB2RELAGAAMAPT
SCHEMBL9545130 0.72 CYP19A1 (0.37) NFKB1NFKB2RELAGAAMAPT
SCHEMBL9545138 0.72 CYP19A1 (0.37) NFKB1NFKB2RELAGAAMAPT
SCHEMBL9275393 0.71 PDK2 (0.33) GAAPDK2ALDH1A1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0636132-A1 SUBSTITUTED NITROGEN CONTAINING SPIRO COMPOUNDS FOR USE IN TREATING COGNITIVE DEFICITS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-02-01 EP disclosed
WO-1993021185-A1 SUBSTITUTED NITROGEN CONTAINING SPIRO COMPOUNDS FOR USE IN TREATING COGNITIVE DEFICITS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-10-28 WO disclosed